Taipei Medical University
  • 2019 Apr 16
  • Taipei Medical University visited Silicon Valley startup accelerator,will introduce the international accelerator mode.

To fully activate the industrialization of Taipei Medical University’s researches, extending the network of contacts and strengthen the international connection is the key to developing talent and industry. Leading by President Lin Chien-huang, Vice President Wu Chieh-hsi, Dean Lin Chun-mao, Dean Tsai Pei-shan , Dean Chen Chih-hwa, Vice Dean Hsu Ming-kuan, Director Chiu Shih-feng, Project Manager Yi Shih-en, Dr. Chen Chao-wei and Dr. Liu Tien-jen formed the Accelerator Visiting Group.

The main purpose of the accelerator is to make startups grow rapidly, including provide workspace, seed funding, mentoring, training and so on. Though the accelerator and the incubator are similar. In general, incubator starts from technology and R&D, then marketing. Accelerator is market-oriented, trough modifying or re-developing the origin research to commercialization. Over these years, the office of business development has assisted R&D team in commoditization, and has enhanced industrial value of research and development, industry-university cooperation, and technology transfer. Taiwan's biomedical industry resources are scattered. In the development of biomedical innovation, to focus on and link resources will be the key point. Now, there is no medical system or universities establish national or international startup acceleration; It will be an advantage for overall industry.
In medical technology, Taiwan is the first in Asia, and the third in the world.

The environment of medical electronics industry is good. Taiwan is also competitive in R&D and quality. Ministry of Science and Technology has trained about 50 physicians and engineers abroad through the STB Project and the BTB Project. Eighteen high-end medical materials startups also have been successfully established. Taiwan values intellectual property rights and regulations, so it is very persuasive and trustworthy for foreign companies and funds. The comprehensive clinical resources and market access of TMU will be a major advantage in developing an international biomedical accelerator.

TMU GLORIA planned the schedule, visiting many well-known accelerators in Silicon Valley, including 500 startups, QB3, SkyDeck, StartX Med, Acron Campus and JLABS@SSF. Those accelerators are good example for TMU, through the visiting, we learned about team coaching, fund operations, resource management and link models. In addition to we can also communicate with their work team to know how to improve our innovation and entrepreneurship environment.

This time, we visited the North American Liaison Office of the ITRI. They will assist TMU in connecting resources from Silicon Valley. We also visited SPARK program of Stanford University and Biodesign Program, through collaboration, we are able to cultivate talents in innovative medical materials.

【Visiting Berkeley University, form left: Director Chiu Shih-feng, Project Manager Yi Shih-en, Dean Lin Chun-mao, Vice President Wu Chieh-hsi, Dr. Anthony St. George, President Lin Chien-huang, Dean Chen Chih-hwa, Dr. Liu Tien-jen, Dr. Chen Chao-wei, and Vice Dean Hsu Ming-kuan.】